Spero Health

What Spero Health does

Spero Health is a private, for-profit integrated healthcare services organization headquartered in Chattanooga, Tennessee, founded in 2018. The company operates a national network of more than 60 outpatient clinics delivering substance use disorder (SUD) treatment and addiction care services directly to patients across the United States. Its clinical offering spans patient intake, treatment delivery, and ongoing engagement, with an explicit focus on longitudinal retention in a population where care continuity is clinically critical.

The company's service delivery is increasingly enabled by an agentic AI operations layer delivered through a strategic partnership with UnityAI (announced 2026-05-20). The UnityAI PatientOps platform automates inbound patient intake, scheduling, and inquiry management across Spero Health's clinic network, with stated plans to extend into outbound communication and longitudinal patient engagement to improve care retention. AI modalities in use are text-based, spanning patient inquiries, scheduling requests, and outbound messaging. Spero Health itself does not market a distinct external software product; the technology is deployed internally to reduce administrative burden and front-line workforce shortages endemic to addiction care.

Spero Health generates revenue through direct patient care services delivered via its clinic network. Its end customers are individuals seeking SUD treatment, served through a direct-to-patient clinic distribution model rather than enterprise sales channels. The leadership team comprises a CEO (Steve Priest), COO (Edward Littlejohn), CFO (Rick Adams), Chief People Officer (Dena Levine), Chief Legal Officer (Justin Page), SVP of Business Development (Mark Rappè), and VP of Technology (Chris Rathermel). No funding rounds, M&A activity, parent company, or disclosed financial figures are present in the source data.

Name

Spero Health

Website

https://sperohealth.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

251–500 employees

Short description

Spero Health is a private outpatient healthcare provider operating 60+ substance use disorder treatment clinics across the United States from its Chattanooga, Tennessee headquarters, serving patients with addiction conditions.

Ownership category

akta.pro rank

Product category

Outpatient Substance Use Disorder Treatment

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)

akta.pro secondary industry

Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)

Keywords

• Outpatient addiction treatment
• Substance use disorder care
• Behavioral health services
• Medication assisted treatment
• Addiction recovery clinics

Headquarters

HQ city

Chattanooga

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Outpatient Healthcare Services: Spero Health generates revenue by providing substance use disorder treatment through its network of over 60 outpatient clinics. Revenue is derived from patient care services, including intake, treatment, and ongoing engagement.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Spero Health operates a national network of over 60 outpatient clinics providing substance use disorder and addiction treatment services, including patient intake, treatment delivery, and longitudinal engagement. The organization internally deploys UnityAI's PatientOps AI platform to automate inbound patient intake, scheduling, and inquiry management, addressing administrative burden and front-line workforce shortages in addiction care.

Product overview

Spero Health is a healthcare services provider operating a network of over 60 outpatient clinics offering substance use disorder treatment. The company does not appear to offer a distinct technology product or software platform for external use; rather, it is a healthcare services organization. In December 2025, Spero Health announced a strategic partnership with UnityAI to deploy UnityAI's PatientOps AI platform internally across its clinic network to automate administrative operations.

Differentiator

Problem solved

Functional benefit

Products and services

• Outpatient Substance Use Disorder Treatment

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Partnerships

One partnership is on record.

• UnityAIcoreTechnology or Integration · 20 May 2026Strategic partnership to deploy UnityAI's PatientOps AI platform across Spero Health's national network of over 60 outpatient clinics. The platform uses agentic AI to automate inbound patient intake, scheduling, and inquiry management. Initial rollout focuses on automated call management with plans to expand into outbound communication and longitudinal patient engagement to improve care retention.

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

Broad incumbents

• Caron Treatment Centers: Long-established nonprofit addiction treatment operator with a national referral base and broader service continuum — competes for the same SUD patient population, though anchored in residential care.
• Recovery Centers of America: Multi-site addiction treatment operator offering both inpatient and outpatient SUD programs — competes for the same patient population and referral channels as Spero Health at greater scale.
• Hazelden Betty Ford Foundation: National nonprofit SUD treatment organization with a broad addiction care continuum including outpatient services, comparable vertical focus but anchored in legacy residential programming.
• Acadia Healthcare: Large publicly traded behavioral health operator with a meaningful SUD treatment portfolio alongside broader psychiatric services — overlapping in clinical focus and operating model, though diversified across inpatient and outpatient lines.

Direct peers

• Pinnacle Treatment Centers: National outpatient and residential SUD treatment operator with a comparable geographic footprint and vertically focused addiction medicine service line.
• CleanSlate Centers: Multi-state outpatient addiction medicine provider focused on medication-assisted treatment and similar SUD services to Spero Health, with comparable clinic-based delivery model.
• American Addiction Centers: National outpatient and residential substance use disorder treatment provider operating a multi-state clinic network — directly comparable to Spero Health's vertically-focused SUD model and geographic footprint.
• BayMark Health Services: National provider of outpatient opioid use disorder treatment and medication-assisted treatment across a large clinic network, with the same SUD specialization, payer mix, and operating scale profile.
• Crossroads Treatment Centers: Multi-state outpatient opioid use disorder treatment network operating on the same clinic-based, medication-assisted treatment paradigm as Spero Health.

Emerging players

• Vertava Health: Multi-state behavioral health and SUD treatment provider with outpatient and residential programs — smaller and more regionally concentrated but overlapping in target patient population.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/SperoHealth1

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Spero Health